US Stock MarketDetailed Quotes

Immunovant (IMVT)

Watchlist
  • 29.300
  • +1.950+7.13%
Close Apr 17 15:59 ET
  • 29.310
  • +0.010+0.03%
Post 17:23 ET
5.96BMarket Cap-10.97P/E (TTM)

Immunovant (IMVT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.05%114.36M
13.84%131.76M
34.94%127.22M
62.15%438.15M
40.73%113.83M
85.70%114.3M
87.29%115.74M
42.90%94.28M
29.74%270.21M
25.86%80.88M
Selling and administrative expenses
-21.96%15.44M
-5.19%17.51M
38.37%26.02M
34.84%77.24M
36.10%20.17M
49.69%19.78M
33.45%18.47M
22.11%18.81M
19.29%57.28M
19.33%14.82M
-General and administrative expense
-21.96%15.44M
-5.19%17.51M
38.37%26.02M
34.84%77.24M
36.10%20.17M
49.69%19.78M
33.45%18.47M
22.11%18.81M
19.29%57.28M
19.33%14.82M
Research and development costs
4.66%98.92M
17.45%114.25M
34.09%101.2M
69.50%360.92M
41.78%93.65M
95.54%94.52M
102.82%97.27M
49.23%75.47M
32.87%212.93M
27.43%66.06M
Operating profit
-0.05%-114.36M
-13.84%-131.76M
-34.94%-127.22M
-62.15%-438.15M
-40.73%-113.83M
-85.70%-114.3M
-87.29%-115.74M
-42.90%-94.28M
-29.74%-270.21M
-25.86%-80.88M
Net non-operating interest income expense
16.19%5.33M
-7.72%5.6M
-11.74%6.34M
-0.87%24.73M
-17.79%6.89M
-48.62%4.59M
70.02%6.07M
76.63%7.18M
229.22%24.95M
140.78%8.38M
Non-operating interest income
16.19%5.33M
-7.72%5.6M
-11.74%6.34M
-0.87%24.73M
-17.79%6.89M
-48.62%4.59M
70.02%6.07M
76.63%7.18M
229.22%24.95M
140.78%8.38M
Other net income (expense)
95.71%-54K
-60.25%250K
4,139.29%1.19M
103.49%471K
141.40%1.07M
-214.99%-1.26M
3,045.00%629K
100.23%28K
-31.75%-13.51M
-826.69%-2.59M
Special income (charges)
----
----
----
--0
--0
--0
--0
--0
-25.00%-12.5M
--0
-Less:Restructuring and merger&acquisition
----
----
----
--0
--0
--0
--0
--0
25.00%12.5M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
25.00%12.5M
--0
Other non- operating income (expenses)
95.71%-54K
-60.25%250K
4,139.29%1.19M
146.73%471K
141.40%1.07M
-214.99%-1.26M
3,045.00%629K
-93.97%28K
-298.42%-1.01M
-826.69%-2.59M
Income before tax
1.70%-109.08M
-15.47%-125.91M
-37.47%-119.7M
-59.58%-412.95M
-40.99%-105.87M
-115.37%-110.97M
-87.33%-109.04M
-17.75%-87.07M
-22.67%-258.77M
-24.27%-75.09M
Income tax
921.05%1.55M
661.54%594K
1,085.71%913K
57.14%891K
151.29%583K
240.74%152K
-82.82%78K
800.00%77K
6,200.00%567K
123.41%232K
Net income
0.44%-110.64M
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
Net income continuous Operations
0.44%-110.64M
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
Minority interest income
Net income attributable to the parent company
0.44%-110.64M
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.44%-110.64M
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
Basic earnings per share
19.74%-0.61
1.35%-0.73
-18.33%-0.71
-45.21%-2.73
-23.08%-0.64
-111.11%-0.76
-64.44%-0.74
-5.26%-0.6
-9.94%-1.88
-13.04%-0.52
Diluted earnings per share
19.74%-0.61
1.35%-0.73
-18.33%-0.71
-45.21%-2.73
-23.08%-0.64
-111.11%-0.76
-64.44%-0.74
-5.26%-0.6
-9.94%-1.88
-13.04%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.05%114.36M13.84%131.76M34.94%127.22M62.15%438.15M40.73%113.83M85.70%114.3M87.29%115.74M42.90%94.28M29.74%270.21M25.86%80.88M
Selling and administrative expenses -21.96%15.44M-5.19%17.51M38.37%26.02M34.84%77.24M36.10%20.17M49.69%19.78M33.45%18.47M22.11%18.81M19.29%57.28M19.33%14.82M
-General and administrative expense -21.96%15.44M-5.19%17.51M38.37%26.02M34.84%77.24M36.10%20.17M49.69%19.78M33.45%18.47M22.11%18.81M19.29%57.28M19.33%14.82M
Research and development costs 4.66%98.92M17.45%114.25M34.09%101.2M69.50%360.92M41.78%93.65M95.54%94.52M102.82%97.27M49.23%75.47M32.87%212.93M27.43%66.06M
Operating profit -0.05%-114.36M-13.84%-131.76M-34.94%-127.22M-62.15%-438.15M-40.73%-113.83M-85.70%-114.3M-87.29%-115.74M-42.90%-94.28M-29.74%-270.21M-25.86%-80.88M
Net non-operating interest income expense 16.19%5.33M-7.72%5.6M-11.74%6.34M-0.87%24.73M-17.79%6.89M-48.62%4.59M70.02%6.07M76.63%7.18M229.22%24.95M140.78%8.38M
Non-operating interest income 16.19%5.33M-7.72%5.6M-11.74%6.34M-0.87%24.73M-17.79%6.89M-48.62%4.59M70.02%6.07M76.63%7.18M229.22%24.95M140.78%8.38M
Other net income (expense) 95.71%-54K-60.25%250K4,139.29%1.19M103.49%471K141.40%1.07M-214.99%-1.26M3,045.00%629K100.23%28K-31.75%-13.51M-826.69%-2.59M
Special income (charges) --------------0--0--0--0--0-25.00%-12.5M--0
-Less:Restructuring and merger&acquisition --------------0--0--0--0--025.00%12.5M--0
-Less:Other special charges --------------------------------25.00%12.5M--0
Other non- operating income (expenses) 95.71%-54K-60.25%250K4,139.29%1.19M146.73%471K141.40%1.07M-214.99%-1.26M3,045.00%629K-93.97%28K-298.42%-1.01M-826.69%-2.59M
Income before tax 1.70%-109.08M-15.47%-125.91M-37.47%-119.7M-59.58%-412.95M-40.99%-105.87M-115.37%-110.97M-87.33%-109.04M-17.75%-87.07M-22.67%-258.77M-24.27%-75.09M
Income tax 921.05%1.55M661.54%594K1,085.71%913K57.14%891K151.29%583K240.74%152K-82.82%78K800.00%77K6,200.00%567K123.41%232K
Net income 0.44%-110.64M-15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M
Net income continuous Operations 0.44%-110.64M-15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M
Minority interest income
Net income attributable to the parent company 0.44%-110.64M-15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.44%-110.64M-15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M
Basic earnings per share 19.74%-0.611.35%-0.73-18.33%-0.71-45.21%-2.73-23.08%-0.64-111.11%-0.76-64.44%-0.74-5.26%-0.6-9.94%-1.88-13.04%-0.52
Diluted earnings per share 19.74%-0.611.35%-0.73-18.33%-0.71-45.21%-2.73-23.08%-0.64-111.11%-0.76-64.44%-0.74-5.26%-0.6-9.94%-1.88-13.04%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More